These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4706699)
1. [Effects of fenfluramine, administered on short or long-term basis, on lipolysis of obese subjects]. Balasse EO Vie Med Can Fr; 1973; 2(2):157-62. PubMed ID: 4706699 [No Abstract] [Full Text] [Related]
3. Anti-obesity action of fenfluramine. Sapeika N Practitioner; 1972 May; 208(247):660-1. PubMed ID: 5070964 [No Abstract] [Full Text] [Related]
4. Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects. Balasse EO; Couturier E; Kornitzer M; Degre S Postgrad Med J; 1975; 51 Suppl 1():157. PubMed ID: 768958 [No Abstract] [Full Text] [Related]
5. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss]. Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388 [TBL] [Abstract][Full Text] [Related]
6. Fenfluramine: Its use in obesity. Sapeika N Cent Afr J Med; 1973 Feb; 19(2):23-4. PubMed ID: 4712236 [No Abstract] [Full Text] [Related]
7. Ascorbic acid and cholesterol mobilization by fenfluramine. Odumosu A; Wilson CW Br J Pharmacol; 1973 Jun; 48(2):326P-327P. PubMed ID: 4733736 [No Abstract] [Full Text] [Related]
8. Fenfluramine in the management of obesity. Datey KK; Kelkar PN; Pandya RS Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613 [No Abstract] [Full Text] [Related]
9. Clinical and biochemical studies on obese subjects using fenfluramine. Abdel-Kader MM; Mashaly M; Abdel-Aziz MT J Egypt Med Assoc; 1974; 57(9-10):433-41. PubMed ID: 4452780 [No Abstract] [Full Text] [Related]
11. [Chronotherapy of obesity. II. Variations in eating behavior in the obese after fenfluramine treatment in relation to time of administration]. Di Vincenzo M; Guagnano MT; Della Loggia F; Sensi S Boll Soc Ital Biol Sper; 1982 Jun; 58(12):740-4. PubMed ID: 7104097 [TBL] [Abstract][Full Text] [Related]
12. [Psychological factors in the etiology of obesity and in the long-term treatment of psychiatric obese]. Gaind R Vie Med Can Fr; 1973; 2(2):171-6. PubMed ID: 4706702 [No Abstract] [Full Text] [Related]
13. Clinical studies with d-fenfluramine. Guy-Grand B Am J Clin Nutr; 1992 Jan; 55(1 Suppl):173S-176S. PubMed ID: 1728829 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of fenfluramine in obese Nigerians--clinical, metabolic and hypotensive properties. Adadevoh BK Postgrad Med J; 1975; 51 Suppl 1():158. PubMed ID: 768959 [No Abstract] [Full Text] [Related]
15. [Control of appetite with dexfenfluramine in treatment of obesity]. Blundell JE; Hill AJ Pol Tyg Lek; 1995; Suppl 1():11-9. PubMed ID: 7596899 [No Abstract] [Full Text] [Related]
16. New treatment for obesity: dexfenfluramine (Redux). Bihm B Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871 [No Abstract] [Full Text] [Related]
17. [Is fenfluramine suitable as a therapeutic principle in obese aged diabetics? (end)]. Förster H; Huth K; Koch E; Tunali G Fortschr Med; 1979 Feb; 97(6):259-62. PubMed ID: 428867 [No Abstract] [Full Text] [Related]
18. [Treatment of heavy obese by high doses of fenfluramine]. Sproule BC Vie Med Can Fr; 1973; 2(2):163-5. PubMed ID: 4706700 [No Abstract] [Full Text] [Related]